ONCODERMA
ActiveSummary
The computed 12-month bankruptcy probability of ONCODERMA is 3.2% (moderate). The 2024 annual accounts show negative equity (-€32,664) and a net result of -€9,156. Equity is shrinking by ~32.9% per year across the filed fiscal years. Its solvency ranks better than 5% of 2025 sector peers (fiscal year 2024). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals.
Directors
Directors
No directors read yet: 0 of 8 Gazette acts processed. See the function holders in the CBE →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.